Global Lanreotide Market Growth 2022-2028
- LP 4871615
- 75 Pages
- February 2022
- Pharmaceuticals
The United States Lanreotide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lanreotide market, reaching US$ million by the year 2028. As for the Europe Lanreotide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lanreotide players cover IPSEN, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lanreotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
60 mg
90 mg
120 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
IPSEN
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lanreotide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lanreotide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lanreotide by Country/Region, 2017, 2022 & 2028
2.2 Lanreotide Segment by Type
2.2.1 60 mg
2.2.2 90 mg
2.2.3 120 mg
2.3 Lanreotide Sales by Type
2.3.1 Global Lanreotide Sales Market Share by Type (2017-2022)
2.3.2 Global Lanreotide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lanreotide Sale Price by Type (2017-2022)
2.4 Lanreotide Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Lanreotide Sales by Application
2.5.1 Global Lanreotide Sale Market Share by Application (2017-2022)
2.5.2 Global Lanreotide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lanreotide Sale Price by Application (2017-2022)
3 Global Lanreotide by Company
3.1 Global Lanreotide Breakdown Data by Company
3.1.1 Global Lanreotide Annual Sales by Company (2020-2022)
3.1.2 Global Lanreotide Sales Market Share by Company (2020-2022)
3.2 Global Lanreotide Annual Revenue by Company (2020-2022)
3.2.1 Global Lanreotide Revenue by Company (2020-2022)
3.2.2 Global Lanreotide Revenue Market Share by Company (2020-2022)
3.3 Global Lanreotide Sale Price by Company
3.4 Key Manufacturers Lanreotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lanreotide Product Location Distribution
3.4.2 Players Lanreotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lanreotide by Geographic Region
4.1 World Historic Lanreotide Market Size by Geographic Region (2017-2022)
4.1.1 Global Lanreotide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lanreotide Annual Revenue by Geographic Region
4.2 World Historic Lanreotide Market Size by Country/Region (2017-2022)
4.2.1 Global Lanreotide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lanreotide Annual Revenue by Country/Region
4.3 Americas Lanreotide Sales Growth
4.4 APAC Lanreotide Sales Growth
4.5 Europe Lanreotide Sales Growth
4.6 Middle East & Africa Lanreotide Sales Growth
5 Americas
5.1 Americas Lanreotide Sales by Country
5.1.1 Americas Lanreotide Sales by Country (2017-2022)
5.1.2 Americas Lanreotide Revenue by Country (2017-2022)
5.2 Americas Lanreotide Sales by Type
5.3 Americas Lanreotide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lanreotide Sales by Region
6.1.1 APAC Lanreotide Sales by Region (2017-2022)
6.1.2 APAC Lanreotide Revenue by Region (2017-2022)
6.2 APAC Lanreotide Sales by Type
6.3 APAC Lanreotide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lanreotide by Country
7.1.1 Europe Lanreotide Sales by Country (2017-2022)
7.1.2 Europe Lanreotide Revenue by Country (2017-2022)
7.2 Europe Lanreotide Sales by Type
7.3 Europe Lanreotide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lanreotide by Country
8.1.1 Middle East & Africa Lanreotide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lanreotide Revenue by Country (2017-2022)
8.2 Middle East & Africa Lanreotide Sales by Type
8.3 Middle East & Africa Lanreotide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lanreotide
10.3 Manufacturing Process Analysis of Lanreotide
10.4 Industry Chain Structure of Lanreotide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lanreotide Distributors
11.3 Lanreotide Customer
12 World Forecast Review for Lanreotide by Geographic Region
12.1 Global Lanreotide Market Size Forecast by Region
12.1.1 Global Lanreotide Forecast by Region (2023-2028)
12.1.2 Global Lanreotide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lanreotide Forecast by Type
12.7 Global Lanreotide Forecast by Application
13 Key Players Analysis
13.1 IPSEN
13.1.1 IPSEN Company Information
13.1.2 IPSEN Lanreotide Product Offered
13.1.3 IPSEN Lanreotide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 IPSEN Main Business Overview
13.1.5 IPSEN Latest Developments
14 Research Findings and Conclusion
Table 1. Lanreotide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lanreotide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 60 mg
Table 4. Major Players of 90 mg
Table 5. Major Players of 120 mg
Table 6. Global Lanreotide Sales by Type (2017-2022) & (K Units)
Table 7. Global Lanreotide Sales Market Share by Type (2017-2022)
Table 8. Global Lanreotide Revenue by Type (2017-2022) & ($ million)
Table 9. Global Lanreotide Revenue Market Share by Type (2017-2022)
Table 10. Global Lanreotide Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Lanreotide Sales by Application (2017-2022) & (K Units)
Table 12. Global Lanreotide Sales Market Share by Application (2017-2022)
Table 13. Global Lanreotide Revenue by Application (2017-2022)
Table 14. Global Lanreotide Revenue Market Share by Application (2017-2022)
Table 15. Global Lanreotide Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Lanreotide Sales by Company (2020-2022) & (K Units)
Table 17. Global Lanreotide Sales Market Share by Company (2020-2022)
Table 18. Global Lanreotide Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Lanreotide Revenue Market Share by Company (2020-2022)
Table 20. Global Lanreotide Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Lanreotide Producing Area Distribution and Sales Area
Table 22. Players Lanreotide Products Offered
Table 23. Lanreotide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Lanreotide Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Lanreotide Sales Market Share Geographic Region (2017-2022)
Table 28. Global Lanreotide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Lanreotide Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Lanreotide Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Lanreotide Sales Market Share by Country/Region (2017-2022)
Table 32. Global Lanreotide Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Lanreotide Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Lanreotide Sales by Country (2017-2022) & (K Units)
Table 35. Americas Lanreotide Sales Market Share by Country (2017-2022)
Table 36. Americas Lanreotide Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Lanreotide Revenue Market Share by Country (2017-2022)
Table 38. Americas Lanreotide Sales by Type (2017-2022) & (K Units)
Table 39. Americas Lanreotide Sales Market Share by Type (2017-2022)
Table 40. Americas Lanreotide Sales by Application (2017-2022) & (K Units)
Table 41. Americas Lanreotide Sales Market Share by Application (2017-2022)
Table 42. APAC Lanreotide Sales by Region (2017-2022) & (K Units)
Table 43. APAC Lanreotide Sales Market Share by Region (2017-2022)
Table 44. APAC Lanreotide Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Lanreotide Revenue Market Share by Region (2017-2022)
Table 46. APAC Lanreotide Sales by Type (2017-2022) & (K Units)
Table 47. APAC Lanreotide Sales Market Share by Type (2017-2022)
Table 48. APAC Lanreotide Sales by Application (2017-2022) & (K Units)
Table 49. APAC Lanreotide Sales Market Share by Application (2017-2022)
Table 50. Europe Lanreotide Sales by Country (2017-2022) & (K Units)
Table 51. Europe Lanreotide Sales Market Share by Country (2017-2022)
Table 52. Europe Lanreotide Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Lanreotide Revenue Market Share by Country (2017-2022)
Table 54. Europe Lanreotide Sales by Type (2017-2022) & (K Units)
Table 55. Europe Lanreotide Sales Market Share by Type (2017-2022)
Table 56. Europe Lanreotide Sales by Application (2017-2022) & (K Units)
Table 57. Europe Lanreotide Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Lanreotide Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Lanreotide Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Lanreotide Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Lanreotide Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Lanreotide Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Lanreotide Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Lanreotide Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Lanreotide Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Lanreotide
Table 67. Key Market Challenges & Risks of Lanreotide
Table 68. Key Industry Trends of Lanreotide
Table 69. Lanreotide Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Lanreotide Distributors List
Table 72. Lanreotide Customer List
Table 73. Global Lanreotide Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Lanreotide Sales Market Forecast by Region
Table 75. Global Lanreotide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Lanreotide Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Lanreotide Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Lanreotide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Lanreotide Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Lanreotide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Lanreotide Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Lanreotide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Lanreotide Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Lanreotide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Lanreotide Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Lanreotide Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Lanreotide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Lanreotide Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Lanreotide Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Lanreotide Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Lanreotide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Lanreotide Revenue Market Share Forecast by Application (2023-2028)
Table 93. IPSEN Basic Information, Lanreotide Manufacturing Base, Sales Area and Its Competitors
Table 94. IPSEN Lanreotide Product Offered
Table 95. IPSEN Lanreotide Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. IPSEN Main Business
Table 97. IPSEN Latest Developments
List of Figures
Figure 1. Picture of Lanreotide
Figure 2. Lanreotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lanreotide Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Lanreotide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lanreotide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 60 mg
Figure 10. Product Picture of 90 mg
Figure 11. Product Picture of 120 mg
Figure 12. Global Lanreotide Sales Market Share by Type in 2021
Figure 13. Global Lanreotide Revenue Market Share by Type (2017-2022)
Figure 14. Lanreotide Consumed in Hospital
Figure 15. Global Lanreotide Market: Hospital (2017-2022) & (K Units)
Figure 16. Lanreotide Consumed in Pharmacy
Figure 17. Global Lanreotide Market: Pharmacy (2017-2022) & (K Units)
Figure 18. Global Lanreotide Sales Market Share by Application (2017-2022)
Figure 19. Global Lanreotide Revenue Market Share by Application in 2021
Figure 20. Lanreotide Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Lanreotide Revenue Market Share by Company in 2021
Figure 22. Global Lanreotide Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Lanreotide Revenue Market Share by Geographic Region in 2021
Figure 24. Global Lanreotide Sales Market Share by Region (2017-2022)
Figure 25. Global Lanreotide Revenue Market Share by Country/Region in 2021
Figure 26. Americas Lanreotide Sales 2017-2022 (K Units)
Figure 27. Americas Lanreotide Revenue 2017-2022 ($ Millions)
Figure 28. APAC Lanreotide Sales 2017-2022 (K Units)
Figure 29. APAC Lanreotide Revenue 2017-2022 ($ Millions)
Figure 30. Europe Lanreotide Sales 2017-2022 (K Units)
Figure 31. Europe Lanreotide Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Lanreotide Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Lanreotide Revenue 2017-2022 ($ Millions)
Figure 34. Americas Lanreotide Sales Market Share by Country in 2021
Figure 35. Americas Lanreotide Revenue Market Share by Country in 2021
Figure 36. United States Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Lanreotide Sales Market Share by Region in 2021
Figure 41. APAC Lanreotide Revenue Market Share by Regions in 2021
Figure 42. China Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Lanreotide Sales Market Share by Country in 2021
Figure 49. Europe Lanreotide Revenue Market Share by Country in 2021
Figure 50. Germany Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Lanreotide Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Lanreotide Revenue Market Share by Country in 2021
Figure 57. Egypt Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Lanreotide Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Lanreotide in 2021
Figure 63. Manufacturing Process Analysis of Lanreotide
Figure 64. Industry Chain Structure of Lanreotide
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
